Cargando…
Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV M(pro)
The 3C-like main proteinase of the severe acute respiratory syndrome (SARS) coronavirus, SARS-CoV M(pro), is widely considered to be a major drug target for the development of anti-SARS treatment. Based on the chemical structure of a lead compound from a previous screening, we have designed and synt...
Autores principales: | Niu, Chunying, Yin, Jiang, Zhang, Jianmin, Vederas, John C., James, Michael N.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127602/ https://www.ncbi.nlm.nih.gov/pubmed/17931870 http://dx.doi.org/10.1016/j.bmc.2007.09.034 |
Ejemplares similares
-
Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics
por: Piplani, Sakshi, et al.
Publicado: (2023) -
A Mechanistic View of Enzyme Inhibition and Peptide Hydrolysis in the Active Site of the SARS-CoV 3C-like Peptidase
por: Yin, Jiang, et al.
Publicado: (2007) -
N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 M(pro) Dimer
por: Arutyunova, Elena, et al.
Publicado: (2021) -
Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase
por: Zhang, Jianmin, et al.
Publicado: (2008) -
3-Chloropyridin-2-amine
por: Hu, Zhi-Nan, et al.
Publicado: (2011)